Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionHamilton Capital, LLC
Latest Disclosed Ownership1,068 shares
Latest Disclosed Value $ 375,937
Hamilton Capital, LLC reports 2.59% increase in ownership of AMGN / Amgen Inc.

On May 15, 2026 - Hamilton Capital, LLC filed a 13F-HR form disclosing ownership of 1,068 shares of Amgen Inc. (MX:AMGN) valued at $375,937 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 15, 2026 disclosing 1,041 shares of Amgen Inc.. This represents a change in shares of 2.59% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMGEN COM 031162100 1,068 27 2.59 376 10.29 0.0195
2026-05-15 2025-12-31 13F AMGEN COM 031162100 1,041 -5 -0.48 341 16.44 0.0170
2025-08-14 2025-06-30 13F AMGEN COM 031162100 1,046 14 1.36 292 -9.03 0.0161
2025-05-16 2025-03-31 13F AMGEN COM 031162100 1,032 -4 -0.39 322 18.89 0.0195
2025-02-14 2024-12-31 13F AMGEN COM 031162100 1,036 -1,015 -49.49 270 -58.84 0.0205
2024-11-15 2024-09-30 13F AMGEN COM 031162100 2,051 24 1.18 657 3.63 0.0487
2024-08-14 2024-06-30 13F AMGEN COM 031162100 2,027 -102 -4.79 633 4.63 0.0481
2024-05-15 2024-03-31 13F AMGEN COM 031162100 2,129 17 0.80 605 -0.49 0.0453
2024-02-14 2023-12-31 13F AMGEN COM 031162100 2,112 161 8.25 608 16.03 0.0488
2023-11-15 2023-09-30 13F AMGEN COM 031162100 1,951 281 16.83 524 41.62 0.0402
2023-08-03 2023-06-30 13F AMGEN COM 031162100 1,670 38 2.33 371 -6.09 0.0259
2023-05-03 2023-03-31 13F AMGEN COM 031162100 1,632 -64 -3.77 395 -11.46 0.0253
2023-02-13 2022-12-31 13F AMGEN COM 031162100 1,696 335 24.61 445 44.95 0.0288
2022-11-08 2022-09-30 13F AMGEN COM 031162100 1,361 110 8.79 307 0.99 0.0209
2022-08-10 2022-06-30 13F AMGEN COM 031162100 1,251 92 7.94 304 8.57 0.0192
2022-05-11 2022-03-31 13F AMGEN COM 031162100 1,159 1,159 280 0.0180
2019-11-13 2019-09-30 13F AMGEN COM 031162100 0 -1,180 -100.00 0 -100.00
2019-08-15 2019-06-30 13F AMGEN COM 031162100 1,180 1,180 217 0.0750
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.